Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
110.4 USD | -1.44% | -0.03% | -10.02% |
13/05 | US reclassification could drive fresh research funding into pot sector | RE |
07/05 | Jazz Pharmaceuticals Insider Sold Shares Worth $548,250, According to a Recent SEC Filing | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.02% | 7.06B | |
+31.37% | 588B | |
-3.11% | 364B | |
+19.56% | 326B | |
+5.17% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+10.63% | 167B | |
+0.51% | 161B |
- Stock Market
- Equities
- JAZZ Stock
- News Jazz Pharmaceuticals plc
- Transcript : Jazz Pharmaceuticals plc, Q2 2023 Earnings Call, Aug 09, 2023